{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T22:51:46Z","timestamp":1695768706352},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The benefits of combination antiretroviral (ARV) prophylaxis for infants whose HIV exposure is recognized near birth have been established, and the benefits of early ARV therapy are well known. Decisions about ARVs can be supported by the probability that the child has acquired HIV.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Using 2005\u20132010 data from Enhanced Perinatal Surveillance of the Centers for Disease Control and Prevention, we developed a tool for use at birth to help predict HIV acquisition of HIV-exposed infants to support ARV management. A logistic regression model, fit using a fully Bayesian approach, was used to determine maternal variables predictive of infant HIV acquisition. We created a score index from these variables, established the sensitivity and specificity of each possible score, and determined the distribution of scores among infants, with and without HIV, in our study population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Multivariable analysis of data from 8740 HIV-exposed infants (176 infected and 8564 uninfected) yielded 4 maternal variables in the perinatal HIV acquisition prediction model: sexually transmitted infection, substance use, last HIV viral load before delivery and ARV use. Using the regression coefficient estimates, we rescaled each possible score to make the maximum score equal to 100. For each score, sensitivity and specificity were determined; the area under the receiver operating characteristic curve was 0.79. Median index scores for infants with HIV and without HIV were 43 (first quartile 27 and third quartile 60), and 12 (first quartile, 0 and thirs quartile, 29), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Decisions to begin infants on 3 ARVs\u2014whether considered therapeutic or prophylactic\u2014can be supported by data available on the day of birth.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002374","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T23:00:49Z","timestamp":1558134049000},"page":"939-943","source":"Crossref","is-referenced-by-count":1,"title":["A Clinical Score to Support Antiretroviral Management of HIV-exposed Infants on the Day of Birth"],"prefix":"10.1097","volume":"38","author":[{"given":"Steven R.","family":"Nesheim","sequence":"first","affiliation":[{"name":"Epidemiology Branch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Rose","sequence":"additional","affiliation":[{"name":"Quantitative Sciences and Data Management Branch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Pan","sequence":"additional","affiliation":[{"name":"Quantitative Sciences and Data Management Branch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Mahle Gray","sequence":"additional","affiliation":[{"name":"HIV Incidence and Case Surveillance Branch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubha","family":"Rao","sequence":"additional","affiliation":[{"name":"Program Evaluation Branch, Division of HIV and AIDS Prevention, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Singh","sequence":"additional","affiliation":[{"name":"HIV Incidence and Case Surveillance Branch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Lampe","sequence":"additional","affiliation":[{"name":"Epidemiology Branch"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/QAD.0b013e328326ca37","article-title":"Effect of early antiretroviral therapy on the risk of AIDS\/death in HIV-infected infants.","volume":"23","author":"Goetghebuer","year":"2009","journal-title":"AIDS"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants.","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0140-6736(13)61409-9","article-title":"Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.","volume":"382","author":"Cotton","year":"2013","journal-title":"Lancet"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.aids.0000200529.64113.3e","article-title":"Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.","volume":"20","author":"Chiappini","year":"2006","journal-title":"AIDS"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-9-140","article-title":"Five year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy.","volume":"9","author":"Chiappini","year":"2009","journal-title":"BMC Infect Dis"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.inf.0000258626.34984.eb","article-title":"Effectiveness of early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants.","volume":"26","author":"Van der Linden","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1086\/425739","article-title":"Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1.","volume":"39","author":"Faye","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa032706","article-title":"A trial of three antiretroviral regimens in HIV-1-infected children.","volume":"350","author":"Luzuriaga","year":"2004","journal-title":"N Engl J Med"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/cid\/cir950","article-title":"Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.","volume":"54","author":"Goetghebuer","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa1302976","article-title":"Absence of detectable HIV-1 viremia after treatment cessation in an infant.","volume":"369","author":"Persaud","year":"2013","journal-title":"N Engl J Med"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamapediatrics.2014.1560","article-title":"Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents.","volume":"168","author":"Persaud","year":"2014","journal-title":"JAMA Pediatr"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/cid\/ciu432","article-title":"Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral blood.","volume":"59","author":"Bitnun","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/QAI.0b013e318256b2f6","article-title":"Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States.","volume":"60","author":"Smith","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ADM.0000000000000123","article-title":"A brief screening tool to assess the risk of contracting HIV infection among active injection drug users.","volume":"9","author":"Smith","year":"2015","journal-title":"J Addict Med"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jpeds.2011.06.053","article-title":"Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis.","volume":"160","author":"Burgard","year":"2012","journal-title":"J Pediatr"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/QAD.0000000000000794","article-title":"Delayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding.","volume":"29","author":"King","year":"2015","journal-title":"AIDS"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1097\/QAD.0000000000001640","article-title":"Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1.","volume":"31","author":"Balasubramanian","year":"2017","journal-title":"AIDS"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"20520","DOI":"10.7448\/IAS.19.1.20520","article-title":"Safety of combination antiretroviral prophylaxis in high-risk HIV-exposed newborns: a retrospective review of the Canadian experience.","volume":"19","author":"Kakkar","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMoa1108275","article-title":"Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.","volume":"366","author":"Nielsen-Saines","year":"2012","journal-title":"N Engl J Med"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/03630242.2010.506153","article-title":"Missed opportunities to prevent perinatal human immunodeficiency virus transmission in 15 jurisdictions in the United States during 2005-2008.","volume":"50","author":"Whitmore","year":"2010","journal-title":"Women Health"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:54:06Z","timestamp":1694559246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002374","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}